Head and Neck Cancer Trial, Recruiting NCT03010150 Sponsor: M.D. Anderson Cancer Center Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT03010150
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are planned to receive radiation treatment aimed at curing cancer of the nasopharynx, oropharynx, hypopharynx, larynx, or an unknown primary cancer that has spread to lymph nodes in the neck
  • People with oropharyngeal (throat) cancer not related to HPV (human papillomavirus) that is classified as stage II through IVb
  • People with HPV-related oropharyngeal cancer at an early tumour stage (T1) with lymph node involvement but no spread to other parts of the body, or with HPV-related oropharyngeal cancer at stage T2 or higher with no spread to other parts of the body
  • People with laryngeal (voice box) cancer classified as stage II through IVb
  • People with hypopharyngeal cancer classified as stage I through IVb
  • People with nasopharyngeal cancer classified as stage I through IVb
  • People with unknown primary cancer that has spread to neck lymph nodes, classified as stage I through III

Who may not be able to join:

  • People who have been diagnosed with another type of cancer, except for common non-melanoma skin cancers
  • People who have previously received treatment for head and neck cancer, or who have previously had radiation to the head or neck area
  • People who have had prior surgery on the head or neck (though biopsies, tonsil removal, and tracheotomy procedures are generally not disqualifying — confirm with trial site)
  • People who already have difficulty swallowing that is unrelated to their cancer diagnosis, such as a swallowing problem caused by a nerve or neurological condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 December 2016
Est. completion
31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adherence to swallowing exercises; Illness perceptions; Effect of social support on coping

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov